TGA Approval

RINVOQ upadacitinib 15 mg modified release tablet blister pack (312687)

ARTG ID

312687

ARTG Name

RINVOQ upadacitinib 15 mg modified release tablet blister pack

Sponsor

AbbVie Pty Ltd

ARTG Date

January 17, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ABBVIE PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01079-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01075-1

Ingredient Name

upadacitinib hemihydrate

Empowering clinical research with data-driven insights and AI-powered tools.